Sanofi-Synthelabo (India) Private Limited, a amalgamated private limited company, was established on 25 October 2002 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2002PTC137682. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹43.15 Cr and a paid-up capital of ₹33.41 Cr.
It upholds a compliant status. Employing 332 professional, Its leadership includes Vaibhav Vinayak Karandikar (Additional Director), Rajaram Narayanan (Director), Praveen Khullar (Director). Past directors included Christophe Germain, Shailesh Kripalu Ayyangar, Francois Pierre Delille. Its latest AGM occurred on 27 November 2020, with the balance sheet filed on 31 March 2020. It is based at Sanofi House, Cts No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai, Maharashtra, 400072.
U24230MH2002PTC137682
137682
25 October 2002
₹43.15 Cr
₹33.41 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Sanofi-Synthelabo (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Vinayak Karandikar | Additional Director | 02 Feb 2021 | Current |
| Rajaram Narayanan | Director | 01 Jan 2018 | Current |
| Praveen Khullar | Director | 14 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2009 | Past |
| Pramod Abcsdd | Managing Director | 01 Jan 2018 | Past |
| Pramod Abcsdd | Director | 07 Mar 2007 | Past |
| Pramod Abcsdd | Director | 23 Oct 2020 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 21 Jan 2015 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 12 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanofi-Synthelabo (India) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16.11% increase. The company also saw a substantial improvement in profitability, with a 91.63% increase in profit. The company's net worth Soared by an impressive increase of 16.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sanofi-Synthelabo (India) had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sanofi-Synthelabo (India) has a workforce of 332 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sanofi-Synthelabo (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi-Synthelabo (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vaibhav Vinayak Karandikar was appointed as a Additional Director was appointed as a Additional Director on 02 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
Progress on Sanofi-Synthelabo (India) Private Limited last Annual general meeting of members was held on 27 Nov 2020 as per latest MCA records. was documented.
Progress on Sanofi-Synthelabo (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
Praveen Khullar was appointed as a Director was appointed as a Director on 14 Dec 2018 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
Progress on Rajaram Narayanan was appointed as a Director was appointed as a Director on 01 Jan 2018 & has been associated with this company since 7 years 10 months . was documented.
The activity Deepa Ramniklal Shah was appointed as a Company Secretary was appointed as a Company Secretary on 30 Mar 2017 & has been associated with this company since 8 years 8 months . was completed.
The CIN of Sanofi-Synthelabo (India) Private Limited is U24230MH2002PTC137682.
Sanofi-Synthelabo (India) Private Limited is headquartered at Sanofi House, Cts No.117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai, Maharashtra, 400072.
Sanofi-Synthelabo (India) Private Limited was incorporated on 25 October 2002.
The current directors of Sanofi-Synthelabo (India) Private Limited are
The primary industry of Sanofi-Synthelabo (India) Private Limited is Pharma.
Sanofi-Synthelabo (India) Private Limited is unlisted.
The authorized capital of Sanofi-Synthelabo (India) Private Limited is ₹43.15 Cr, and the paid-up capital is ₹33.41 Cr.
The compliance status of Sanofi-Synthelabo (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX